|
US3906092A
(en)
*
|
1971-11-26 |
1975-09-16 |
Merck & Co Inc |
Stimulation of antibody response
|
|
GB2134869A
(en)
|
1983-02-15 |
1984-08-22 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
|
US5897873A
(en)
*
|
1984-04-12 |
1999-04-27 |
The Liposome Company, Inc. |
Affinity associated vaccine
|
|
US6090406A
(en)
*
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5545412A
(en)
|
1985-01-07 |
1996-08-13 |
Syntex (U.S.A.) Inc. |
N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor
|
|
US4806352A
(en)
*
|
1986-04-15 |
1989-02-21 |
Ribi Immunochem Research Inc. |
Immunological lipid emulsion adjuvant
|
|
US4803070A
(en)
*
|
1986-04-15 |
1989-02-07 |
Ribi Immunochem Research Inc. |
Immunological emulsion adjuvants for polysaccharide vaccines
|
|
US4806350A
(en)
*
|
1986-04-18 |
1989-02-21 |
Norden Laboratories, Inc. |
Vaccine formulation
|
|
US5084269A
(en)
*
|
1986-11-06 |
1992-01-28 |
Kullenberg Fred W |
Adjuvant for dose treatment with antigens
|
|
US4920016A
(en)
*
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US6093406A
(en)
*
|
1988-06-02 |
2000-07-25 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccine for induction of immunity to malaria
|
|
HU212924B
(en)
*
|
1989-05-25 |
1996-12-30 |
Chiron Corp |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
FR2649013B1
(fr)
*
|
1989-07-03 |
1991-10-25 |
Seppic Sa |
Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
|
|
US5015476A
(en)
*
|
1989-08-11 |
1991-05-14 |
Paravax, Inc. |
Immunization implant and method
|
|
US5013556A
(en)
*
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
|
US5091188A
(en)
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
|
ES2112274T5
(es)
|
1990-05-29 |
2006-03-01 |
Wyeth Holdings Corporation |
Vacuna contra la pneumonia en cerdos y metodo para la preparacion de la misma.
|
|
FI925835A0
(fi)
|
1990-06-29 |
1992-12-22 |
Chiron Corp |
Vacciner innehaollande liposomer
|
|
US5709879A
(en)
*
|
1990-06-29 |
1998-01-20 |
Chiron Corporation |
Vaccine compositions containing liposomes
|
|
KR100252371B1
(ko)
|
1990-12-12 |
2000-05-01 |
포터 더글라스 |
서브유니트 파필로마비루스 백신 및 그들에 사용하기 위한 펩티드
|
|
CA2072249C
(en)
|
1991-06-28 |
2003-06-17 |
Saiko Hosokawa |
Human monoclonal antibody specifically binding to surface antigen of cancer cell membrane
|
|
HUT70269A
(en)
|
1991-08-13 |
1995-09-28 |
Biotech Australia Pty Ltd |
Immunostimulating compositions and their use
|
|
US6037135A
(en)
*
|
1992-08-07 |
2000-03-14 |
Epimmune Inc. |
Methods for making HLA binding peptides and their uses
|
|
CA2131442A1
(en)
|
1992-03-03 |
1993-09-04 |
Seishi Tsuchiya |
Oral vaccine
|
|
US5855894A
(en)
*
|
1992-03-30 |
1999-01-05 |
Pfizer Inc. |
Pasteurella haemolytica type A-1 bacterin-toxoid vaccine
|
|
US5736141A
(en)
*
|
1992-06-05 |
1998-04-07 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and Freund's adjuvant
|
|
USRE37224E1
(en)
*
|
1992-06-05 |
2001-06-12 |
Dalhousie University |
Method to prevent fertilization in mammals by administering a single dose of zona pellucida derived antigens, liposome and adjuvant
|
|
WO1993025231A1
(en)
|
1992-06-05 |
1993-12-23 |
Dalhousie University |
Use of zona pellucida glycoproteins for immunocontraception
|
|
SI9300468A
(en)
*
|
1992-10-14 |
1994-06-30 |
Hoffmann La Roche |
Injectable composition for the sustained release of biologically active compounds
|
|
US5820879A
(en)
*
|
1993-02-12 |
1998-10-13 |
Access Pharmaceuticals, Inc. |
Method of delivering a lipid-coated condensed-phase microparticle composition
|
|
JPH06247842A
(ja)
*
|
1993-02-23 |
1994-09-06 |
Green Cross Corp:The |
リポソーム組成物の製造方法
|
|
JPH09502086A
(ja)
|
1993-08-06 |
1997-03-04 |
サイテル コーポレイション |
完全ｍａｇｅ１遺伝子のクローニング及び特性決定
|
|
US20050049197A1
(en)
|
1993-09-14 |
2005-03-03 |
Epimmune Inc. |
Induction of immune response against desired determinants
|
|
DE69533693T2
(de)
|
1994-02-24 |
2005-12-22 |
Novavax Inc.(n.d.Ges.d.Staates Delaware) |
Impfstoffe, die paucilamelläre Lipidvesikel als Adjuvans enthalten
|
|
US5874560A
(en)
|
1994-04-22 |
1999-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Melanoma antigens and their use in diagnostic and therapeutic methods
|
|
ATE196297T1
(de)
|
1994-05-18 |
2000-09-15 |
Synthetic Peptides Inc |
Heterodimere trägerzusammensetzung von immunogenen polypeptiden und verfahren zu deren verwendung
|
|
CA2191362A1
(en)
*
|
1994-06-02 |
1995-12-14 |
Mark Selby |
Nucleic acid immunization using a virus-based infection/transfection system
|
|
US5688772A
(en)
|
1994-08-01 |
1997-11-18 |
University Of Saskatchewan |
Quinoa saponin compositions and methods of use
|
|
US5637300A
(en)
*
|
1994-08-03 |
1997-06-10 |
Dunbar; Bonnie S. |
Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception
|
|
US6355256B1
(en)
|
1994-09-30 |
2002-03-12 |
Ludwig Institute For Cancer Research |
Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof
|
|
FR2726764B1
(fr)
*
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
GB9422990D0
(en)
|
1994-11-15 |
1995-01-04 |
Cortecs Ltd |
Immunogenic compositions
|
|
FR2732895B1
(fr)
*
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
US6846489B1
(en)
*
|
1995-04-25 |
2005-01-25 |
Smithkline Beecham Biologicals S.A. |
Vaccines containing a saponin and a sterol
|
|
US5705151A
(en)
*
|
1995-05-18 |
1998-01-06 |
National Jewish Center For Immunology & Respiratory Medicine |
Gene therapy for T cell regulation
|
|
AU6330896A
(en)
*
|
1995-06-07 |
1996-12-30 |
Governors Of The University Of Alberta, The |
A method for eliciting a th1-specific immune response
|
|
JP3098401B2
(ja)
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
US6096313A
(en)
*
|
1996-02-09 |
2000-08-01 |
Ludwig Institute For Cancer Research |
Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant
|
|
US7019112B1
(en)
*
|
1996-03-19 |
2006-03-28 |
University Of Virginia Patent Foundation |
Peptides recognized by melanoma-specific A1-, A2- and A3-restricted cytoxic lymphocytes, and uses therefor
|
|
WO1997046204A2
(en)
*
|
1996-06-05 |
1997-12-11 |
Ashmont Holdings Limited |
Injectable compositions
|
|
US5919480A
(en)
*
|
1996-06-24 |
1999-07-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Liposomal influenza vaccine composition and method
|
|
US6284267B1
(en)
*
|
1996-08-14 |
2001-09-04 |
Nutrimed Biotech |
Amphiphilic materials and liposome formulations thereof
|
|
US5910306A
(en)
*
|
1996-11-14 |
1999-06-08 |
The United States Of America As Represented By The Secretary Of The Army |
Transdermal delivery system for antigen
|
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
CA2203843C
(en)
*
|
1997-04-28 |
2013-07-23 |
Her Majesty The Queen, In Right Of Canada, As Represented By The Ministe R Of National Defence |
Liposome-encapsulated poly iclc
|
|
US6080725A
(en)
*
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
WO1998053799A2
(en)
|
1997-05-28 |
1998-12-03 |
Jenner Biotherapies, Inc. |
Immunogenic compositions
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US6372454B2
(en)
*
|
1997-08-29 |
2002-04-16 |
Human Genome Sciences, Inc. |
Nucleic acid molecules encoding Follistatin-3
|
|
GB9718901D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Smithkline Beecham Biolog |
Vaccine
|
|
US6291430B1
(en)
*
|
1997-09-12 |
2001-09-18 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
US6183746B1
(en)
*
|
1997-10-09 |
2001-02-06 |
Zycos Inc. |
Immunogenic peptides from the HPV E7 protein
|
|
AUPP060097A0
(en)
*
|
1997-11-28 |
1998-01-08 |
Commonwealth Scientific And Industrial Research Organisation |
Adjuvant system for enhanced response
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
ES2175668T3
(es)
*
|
1997-12-16 |
2002-11-16 |
Chiron Corp |
Uso de microparticulas combinadas con emulsiones de aceite en agua submicronicas.
|
|
ATE356630T1
(de)
|
1998-04-03 |
2007-04-15 |
Univ Iowa Res Found |
Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
|
|
US6588671B2
(en)
|
1998-04-09 |
2003-07-08 |
Dcard, Inc. |
Positioning of a recording head for a data storage device
|
|
SE9801288D0
(sv)
*
|
1998-04-14 |
1998-04-14 |
Astra Ab |
Vaccine delivery system and metod of production
|
|
US6472375B1
(en)
*
|
1998-04-16 |
2002-10-29 |
John Wayne Cancer Institute |
DNA vaccine and methods for its use
|
|
US6632447B1
(en)
|
1998-05-07 |
2003-10-14 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
|
HK1039072A1
(zh)
*
|
1998-05-07 |
2002-04-12 |
科里克萨有限公司 |
佐剂组合物及其使用方法
|
|
US6406719B1
(en)
*
|
1998-05-13 |
2002-06-18 |
Microbiological Research Authority |
Encapsulation of bioactive agents
|
|
GB9810236D0
(en)
*
|
1998-05-13 |
1998-07-08 |
Microbiological Res Authority |
Improvements relating to encapsulation of bioactive agents
|
|
US6881405B2
(en)
*
|
1998-06-15 |
2005-04-19 |
Altarex Medical Corp. |
Reagents and methods for inducing an immune response to prostate specific antigen
|
|
US20030044454A1
(en)
*
|
1998-06-30 |
2003-03-06 |
Masaru Fukui |
Compositions containing liposomes and/or emulsions and process for the preparation thereof
|
|
FR2781160B1
(fr)
*
|
1998-07-03 |
2000-08-18 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique pour adjuver un vaccin sous-unitaire
|
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
|
US7087236B1
(en)
*
|
1998-09-01 |
2006-08-08 |
Merrion Research I Limited |
Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof
|
|
US20050084524A1
(en)
*
|
1998-09-30 |
2005-04-21 |
Alza Corporation |
Method for potentiating activity of a chemotherapeutic drug
|
|
US6787154B2
(en)
*
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
GB2345010B
(en)
|
1998-12-17 |
2002-12-31 |
Electrosols Ltd |
A delivery device
|
|
US6790457B1
(en)
*
|
1998-12-22 |
2004-09-14 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
WO2000037100A2
(en)
|
1998-12-22 |
2000-06-29 |
Dalhousie University |
Compositions and methods for reducing or preventing fertilization in fish and birds
|
|
AU769539B2
(en)
*
|
1999-01-29 |
2004-01-29 |
Zoetis Services Llc |
Adjuvants for use in vaccines
|
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
DE60014076T2
(de)
*
|
1999-04-19 |
2005-10-13 |
Glaxosmithkline Biologicals S.A. |
Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
|
|
ID30407A
(id)
|
1999-05-13 |
2001-11-29 |
American Cyanamid Co |
Formulasi-formulasi kombinasi bahan penambah
|
|
US6670195B1
(en)
|
1999-05-26 |
2003-12-30 |
New York University |
Mutant genes in Familial British Dementia and Familial Danish Dementia
|
|
JP2003501376A
(ja)
|
1999-06-04 |
2003-01-14 |
スカイファーマ インコーポレーテッド |
疎水性薬物の持続性放出のための油コア組成物
|
|
GB9923176D0
(en)
*
|
1999-09-30 |
1999-12-01 |
Smithkline Beecham Biolog |
Novel composition
|
|
DE60043708D1
(de)
*
|
1999-10-13 |
2010-03-04 |
Novartis Vaccines & Diagnostic |
Verfahren zur erhaltung zellimmuneantworten gegen proteinen
|
|
US6605696B1
(en)
*
|
1999-10-22 |
2003-08-12 |
Pfizer, Inc. |
Lawsonia intracellularis proteins, and related methods and materials
|
|
US6511676B1
(en)
*
|
1999-11-05 |
2003-01-28 |
Teni Boulikas |
Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes
|
|
US6248353B1
(en)
|
1999-12-10 |
2001-06-19 |
Dade Behring Inc. |
Reconstitution of purified membrane proteins into preformed liposomes
|
|
US7026443B1
(en)
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
|
US6602510B1
(en)
|
2000-04-05 |
2003-08-05 |
Epimmune Inc. |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
|
US6228648B1
(en)
*
|
2000-03-17 |
2001-05-08 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ADAM10 expression
|
|
AU2001245823A1
(en)
|
2000-03-17 |
2001-10-03 |
Corixa Corporation |
Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
|
|
US7449557B2
(en)
|
2000-06-02 |
2008-11-11 |
University Of Connecticut Health Center |
Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
EP1333858B8
(en)
*
|
2000-11-07 |
2006-06-14 |
Immunovaccine Technologies Inc. |
Vaccines with enhanced immune response and methods for their preparation
|
|
EP1343476B1
(en)
|
2000-12-01 |
2008-05-28 |
Biomira Inc. |
Preparation of large liposomes by infusion into peg
|
|
AU2002219711B8
(en)
|
2000-12-08 |
2006-03-02 |
Academisch Ziekenhuis Leiden |
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
|
|
WO2002053106A2
(en)
*
|
2001-01-05 |
2002-07-11 |
Joslin Diabetes Center, Inc. |
Autoantigen composition
|
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
|
CN1168740C
(zh)
*
|
2001-04-04 |
2004-09-29 |
上海美恩生物技术有限公司 |
细胞因子基因修饰的抗原提呈细胞/肿瘤细胞偶联物、其制法和用途
|
|
US6676958B2
(en)
*
|
2001-06-19 |
2004-01-13 |
Advanced Bioadjuvants, Llc |
Adjuvant composition for mucosal and injection delivered vaccines
|
|
EP1410806A4
(en)
*
|
2001-07-25 |
2007-07-04 |
Mitsubishi Pharma Corp |
MEDICINE FOR THE TREATMENT OF BREAST CANCER
|
|
JP4519461B2
(ja)
*
|
2001-07-31 |
2010-08-04 |
ユニヴァーシティ オブ ワシントン |
免疫学的に重要な単純ヘルペスウイルス抗原およびそれを用いる方法
|
|
GB0127564D0
(en)
*
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
|
US6517816B1
(en)
|
2001-12-26 |
2003-02-11 |
Avon Products, Inc. |
Sunscreen emulsion composition and method of use
|
|
AU2003244428A1
(en)
|
2002-02-08 |
2003-09-02 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US7056515B2
(en)
*
|
2002-02-08 |
2006-06-06 |
Immunovaccine Technologies Inc. |
Antigens for immunocontraception
|
|
US20030220284A1
(en)
|
2002-02-22 |
2003-11-27 |
Patricia Yotnda |
Delivery of adenoviral DNA in a liposomal formulation for treatment of disease
|
|
WO2004000873A2
(en)
|
2002-06-25 |
2003-12-31 |
City Of Hope |
Adjuvant-free peptide vaccine
|
|
US20040213837A1
(en)
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
CN1289142C
(zh)
*
|
2002-08-09 |
2006-12-13 |
中国科学院上海生命科学研究院 |
含sa脂质体作为药物载体的药物新剂型
|
|
AU2003268087A1
(en)
|
2002-08-23 |
2004-03-11 |
Ian Ma |
Liposomal gemcitabine compositions for better drug delivery
|
|
EP1393720A1
(en)
*
|
2002-08-27 |
2004-03-03 |
Universiteit Utrecht |
Vesicle-encapsulated corticosteroids for treatment of cancer
|
|
US7179645B2
(en)
|
2002-09-24 |
2007-02-20 |
Antigen Express, Inc. |
Ii-Key/antigenic epitope hybrid peptide vaccines
|
|
DE10249401A1
(de)
|
2002-10-23 |
2004-05-13 |
Bernina Biosystems Gmbh |
Liposomen formende Zusammensetzung
|
|
US20050158375A1
(en)
*
|
2002-11-15 |
2005-07-21 |
Toshikiro Kimura |
Pharmaceutical composition containing liposomes for treating cancer
|
|
CA2511775A1
(en)
|
2002-12-10 |
2004-06-24 |
Epimmune Inc. |
Hla-a1,-a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions
|
|
PT1992635E
(pt)
|
2002-12-23 |
2012-03-20 |
Dynavax Tech Corp |
Oligonucleótidos de sequência imunoestimuladora e métodos de utilização dos mesmos
|
|
AU2003299994A1
(en)
|
2002-12-27 |
2004-07-29 |
Chiron Corporation |
Immunogenic compositions containing phospholpid
|
|
US20040223977A1
(en)
|
2003-02-03 |
2004-11-11 |
City Of Hope |
Fusion peptide HIV vaccines
|
|
EA200501285A1
(ru)
|
2003-02-11 |
2006-02-24 |
Неофарм, Инк. |
Способ получения липосомальных препаратов
|
|
US20050118154A1
(en)
*
|
2003-04-02 |
2005-06-02 |
Mien-Chie Hung |
Antitumor effect of mutant Bik
|
|
KR100720213B1
(ko)
|
2003-04-04 |
2007-05-21 |
화이자 프로덕츠 인코포레이티드 |
미세 유동화된 수중 유적형 유화액 및 백신 조성물
|
|
ES2456666T3
(es)
|
2003-04-18 |
2014-04-23 |
Biotech Synergy, Inc. |
Péptidos antígenos HLA-A2 asociados a un tumor y composiciones
|
|
US20050002999A1
(en)
*
|
2003-06-04 |
2005-01-06 |
Rahul Mehta |
Long-circulating liposomal compositions
|
|
US20050013812A1
(en)
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
WO2005035714A2
(en)
|
2003-08-26 |
2005-04-21 |
Board Of Regents, The University Of Texas System |
Vaccines for cancer, autoimmune disease and infections
|
|
US20050220781A1
(en)
|
2003-09-04 |
2005-10-06 |
Duen-Hwa Yan |
IFIX, a novel HIN-200 protein, for cancer therapy
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
GB0323965D0
(en)
*
|
2003-10-13 |
2003-11-19 |
Glaxosmithkline Biolog Sa |
Immunogenic compositions
|
|
US20050266066A1
(en)
|
2003-10-20 |
2005-12-01 |
Nof Corporation |
Phospholipid membrane preparation
|
|
JP2007533647A
(ja)
*
|
2003-10-24 |
2007-11-22 |
アルザ・コーポレーシヨン |
脂質粒子の調製
|
|
ATE434431T1
(de)
*
|
2003-11-14 |
2009-07-15 |
Het Nl Kanker I The Netherland |
Pharmazeutische formulierungen mit kurzketten- sphingolipiden und ihre verwendung
|
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
|
AU2005222776A1
(en)
|
2003-12-31 |
2005-09-29 |
Genimmune N.V. |
Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
|
|
EP1711208A2
(en)
|
2004-01-28 |
2006-10-18 |
Curix APS |
Conjugates of amyloid proteins as vaccines for amyloid-related diseases
|
|
US7816131B2
(en)
|
2004-04-02 |
2010-10-19 |
Board Of Regents, The University Of Texas System |
Cancer specific promoters
|
|
AU2005230708B2
(en)
|
2004-04-05 |
2009-01-15 |
Zoetis Services Llc |
Microfluidized oil-in-water emulsions and vaccine compositions
|
|
GB0408164D0
(en)
*
|
2004-04-13 |
2004-05-19 |
Immune Targeting Systems Ltd |
Antigen delivery vectors and constructs
|
|
US8241670B2
(en)
|
2004-04-15 |
2012-08-14 |
Chiasma Inc. |
Compositions capable of facilitating penetration across a biological barrier
|
|
US7811602B2
(en)
*
|
2004-05-17 |
2010-10-12 |
Tekmira Pharmaceuticals Corporation |
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
|
|
WO2006050155A2
(en)
|
2004-10-29 |
2006-05-11 |
Biomune, Inc. |
Cancer therapeutic compositions
|
|
US8337815B2
(en)
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
|
EP1838338A2
(en)
|
2004-12-29 |
2007-10-03 |
Mannkind Corporation |
Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs
|
|
WO2006113679A2
(en)
*
|
2005-04-15 |
2006-10-26 |
Board Of Regents, The University Of Texas System |
Delivery of sirna by neutral lipid compositions
|
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
|
US8703095B2
(en)
*
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
US20070059318A1
(en)
*
|
2005-08-15 |
2007-03-15 |
Balu-Iyer Sathy V |
Lipid nano particulates containing antigens as cancer vaccines
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
AU2006322073A1
(en)
|
2005-12-07 |
2007-06-14 |
Hemispherx Biopharma, Inc. |
dsRNAs as influenza virus vaccine adjuvants or immuno-stimulants
|
|
PL1973564T3
(pl)
|
2005-12-22 |
2017-04-28 |
Glaxosmithkline Biologicals S.A. |
Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae
|
|
DK1989224T3
(da)
*
|
2006-02-24 |
2011-02-14 |
Us Gov Health & Human Serv |
Immunogene peptider og anvendelsesmetoder
|
|
WO2007100699A2
(en)
*
|
2006-02-24 |
2007-09-07 |
Novartis Ag |
Microparticles containing biodegradable polymer and cationic polysaccharide for use in immunogenic compositions
|
|
EP2441493B1
(en)
*
|
2006-03-14 |
2014-05-07 |
Oregon Health and Science University |
Methods for producing an immune response to tuberculosis
|
|
AU2007235463B2
(en)
|
2006-03-30 |
2012-11-22 |
The Research Foundation Of State University Of New York |
Compositions of less immunogenic and long-circulating protein-lipid complexes
|
|
CA2654271A1
(en)
|
2006-06-28 |
2008-01-03 |
Statens Serum Institut |
Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
|
|
US20080014217A1
(en)
*
|
2006-07-17 |
2008-01-17 |
Emmanuel Jules Hanon |
Influenza vaccine
|
|
US8877206B2
(en)
*
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
CA2700808C
(en)
*
|
2007-09-27 |
2017-11-14 |
Immunovaccine Technologies Inc. |
Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
|
|
CN101815529B
(zh)
|
2007-10-03 |
2016-03-09 |
免疫疫苗技术有限公司 |
包含抗原、两性化合物和疏水载体的组合物及其应用
|